These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8545918)
1. [Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?]. Nygaard B; Faber JO; Hegedüs L Ugeskr Laeger; 1995 Dec; 157(50):7003-6. PubMed ID: 8545918 [TBL] [Abstract][Full Text] [Related]
2. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Nygaard B; Faber J; Hegedüs L Clin Endocrinol (Oxf); 1994 Dec; 41(6):715-8. PubMed ID: 7889605 [TBL] [Abstract][Full Text] [Related]
3. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994 [TBL] [Abstract][Full Text] [Related]
4. Radioiodine treatment of multinodular non-toxic goitre. Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123 [TBL] [Abstract][Full Text] [Related]
5. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951 [TBL] [Abstract][Full Text] [Related]
6. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
7. Radioiodine for nontoxic multinodular goiter. Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693 [TBL] [Abstract][Full Text] [Related]
8. [The efficacy of the radioiodine treatment of toxic thyroid adenoma and multinodular goiter]. Gómez-Arnaiz N; Maravall J; Gómez JM; Gumà A; Andía E; Mora J Rev Clin Esp; 1999 Oct; 199(10):637-40. PubMed ID: 10589246 [TBL] [Abstract][Full Text] [Related]
9. [Autoimmunization and multinodular large toxic goiter therapy using repeated doses of 131I]. Pisarek M; Baczyk M; Gryczyńska M; Pietz L; Ziemnicka K; Sowiński J Pol Arch Med Wewn; 2006 Jun; 115(6):545-50. PubMed ID: 17263226 [TBL] [Abstract][Full Text] [Related]
11. Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons. Ceccarelli C; Brozzi F; Bianchi F; Santini P Minerva Endocrinol; 2010 Sep; 35(3):161-71. PubMed ID: 20938419 [TBL] [Abstract][Full Text] [Related]
12. Serum thyroxine and age--rather than thyroid volume and serum TSH--are determinants of the thyroid radioiodine uptake in patients with nodular goiter. Bonnema SJ; Fast S; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Hegedüs L J Endocrinol Invest; 2011 Mar; 34(3):e52-7. PubMed ID: 20834199 [TBL] [Abstract][Full Text] [Related]
13. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity. Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467 [TBL] [Abstract][Full Text] [Related]
14. [Long-term effect of 131I therapy of multinodular non-toxic goiter]. Nygaard B; Hegedüs L; Gervil M; Jensen HH; Søe-Jensen P; Hansen JE Ugeskr Laeger; 1994 Sep; 156(39):5699-703. PubMed ID: 7985257 [TBL] [Abstract][Full Text] [Related]
15. Thyroid volume and function after 131I treatment of diffuse non-toxic goitre. Nygaard B; Farber J; Veje A; Hansen JE Clin Endocrinol (Oxf); 1997 Apr; 46(4):493-6. PubMed ID: 9196613 [TBL] [Abstract][Full Text] [Related]
16. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. Hegedüs L; Hansen BM; Knudsen N; Hansen JM BMJ; 1988 Sep; 297(6649):661-2. PubMed ID: 3179549 [No Abstract] [Full Text] [Related]
17. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter. Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812 [TBL] [Abstract][Full Text] [Related]
18. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter. Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701 [TBL] [Abstract][Full Text] [Related]
19. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH). Bonnema SJ; Nielsen VE; Hegedüs L Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838 [TBL] [Abstract][Full Text] [Related]
20. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]